Reckitt Benckiser Pharmaceuticals Inc. (RBGPY) recently announced that it has received approval for two new dosages (4mg and 12 mg) of Suboxone (buprenorphine and naloxone) sublingual film from the US Food and Drug Administration...
30Aug2012 | vitalstocks
| Comments Off
by Matt Weinschenk, Senior Analyst, The White Cap...
18Feb2009 | InvestmentU
| 0 comments